Skip to content
20-F

Annual Report (Foreign)

Lichen International Limited LICN

0001213900-25-036244

← back to feed
Filed
Apr 29, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents FY 2024 · Dec 31, 2023 $25.86M
Stockholders Equity FY 2024 · Dec 31, 2023 $61.42M
Current Liabilities FY 2024 · Dec 31, 2023 $4.09M
Total Liabilities FY 2024 · Dec 31, 2023 $4.13M
Current Assets FY 2024 · Dec 31, 2023 $40.13M
Total Assets FY 2024 · Dec 31, 2023 $65.55M
Shares Diluted restated FY 2024 · Dec 31, 2022 112.5K sh
Capex FY 2024 · Dec 31, 2022 $1.95M
Operating Cash Flow FY 2024 · Dec 31, 2022 $10.77M
Eps Diluted restated FY 2024 · Dec 31, 2022 $69.50
Eps Basic restated FY 2024 · Dec 31, 2022 $69.50
Sga Expense FY 2024 · Dec 31, 2022 $7.43M
Net Income FY 2024 · Dec 31, 2022 $7.82M
Operating Income FY 2024 · Dec 31, 2022 $10.65M
Gross Profit FY 2024 · Dec 31, 2022 $20.19M
Cost Of Revenue FY 2024 · Dec 31, 2022 $13.61M